AAV	Adeno-Associated Virus
APCs	Antigen Presenting Cells
B-CLL	B-Cell Chronic Lymphocytic Leukemia
CD28	Cluster of Differentiation 28
CD80/CD86	B7-1/B7-2 (co-stimulatory molecules)
CTLA-4	Cytotoxic T-Lymphocyte-Associated Protein 4
DCs	Dendritic Cells
EMT	Epithelial–Mesenchymal Transition
GMP	Good Manufacturing Practice
H&E	Hematoxylin and Eosin (staining)
HNSCC	Head and Neck Squamous Cell Carcinoma
ICI/ICIs	Immune Checkpoint Inhibitor(s)
IFN-γ	Interferon Gamma
IL	Interleukin
LAG-3	Lymphocyte Activation Gene-3
LNA	Locked Nucleic Acid
MHC-I	Major Histocompatibility Complex Class I
miRNA/miRs	microRNA
mTOR	Mammalian Target of Rapamycin
NK cells	Natural Killer Cells
NSCLC	Non-Small Cell Lung Cancer
PARP	Poly (ADP-Ribose) Polymerase
PD-1	Programmed Cell Death Protein 1
PD-L1	Programmed Death-Ligand 1
R-CHOP	Rituximab + Cyclophosphamide, Doxorubicin, Vincristine, Prednisone
OC	Ovarian Cancer
RISC	RNA-Induced Silencing Complex
TAMs	Tumor-Associated Macrophages
TCR	T-Cell Receptor
TIM-3	T-Cell Immunoglobulin and Mucin Domain-Containing Protein 3
TME	Tumor Microenvironment
TNBC	Triple-Negative Breast Cancer
TNF-α	Tumor Necrosis Factor Alpha
Treg	Regulatory T cells
UMAP	Uniform Manifold Approximation and Projection